They say RFK Jr. would threaten the achievements - including combating deadly diseases and monitoring drug safety - of a science-based public health order painstakingly built since World War II.

Vaccine makers hit hardest as Robert F. Kennedy Jr. appointment to Department of Health raises concerns for US drug market.

FTSE 100 and 250 decline as AstraZeneca and GSK weigh down. UK economy contracts in surprise September downturn, impacting growth prospects.

Stocks of major drug makers and biotech companies tumbled in the first full day of trading after Donald Trump announced that he wants vaccine skeptic Robert F.

Vaccine stocks have struggled since RFK Jr.'s appointment to health secretary, with Moderna and Pfizer seeing the deepest ...

Deutsche Bank analyst Emmanuel Papadakis downgraded GSK (GSK) to Hold from Buy with a price target of 1,350 GBp, down from 1,700 GBp.

The inability of COVID vaccines to reach the long-lived plasma cell compartment in the bone marrow may explain their waning ...

Shares of leading vaccine producers, such as Pfizer and Moderna, experienced notable drops after Robert F. Kennedy Jr. was ...

The news prompted a sell-off across the industry. In the US, shares in Pfizer sank more than 4% and Moderna were roughly 9% ...

Sellers hit tech stocks in stock market today as bond yields spiked, but selling was muted in the Russell 2000 small-cap ...

The UK stock market experienced declines with significant impacts from AstraZeneca and GSK, contributing to the FTSE 100's ...

The dry powder inhaler market is projected to be worth USD 20.83 billion in 2024. The market is likely to reach USD 29.95 ...